Association between vitamin D 3 supplementation and serum 25- hydroxyvitamin D levels in older individuals residing in long-term care in Ontario, Canada

Journal of the American Geriatrics Society

Volumn 60, Issue 5, 2012, Pages 985-987

  Ioannidis, George ^a   Kennedy, Courtney C ^a   Dykeman, Joanne ^b   Dudziak, Sandra ^b   Papaioannou, Alexandra ^a  

^a MCMASTER UNIVERSITY   (Canada)

^b Revera Inc Ontario   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; COLECALCIFEROL; 25-HYDROXYVITAMIN D; DRUG DERIVATIVE; VITAMIN; VITAMIN D;

AGED; CANADA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; FRAGILITY FRACTURE; HEALTH PROGRAM; HUMAN; INFORMED CONSENT; LETTER; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OSTEOLYSIS; OSTEOPOROSIS; PALLIATIVE THERAPY; PREVALENCE; RESIDENT; RISK FACTOR; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; BLOOD; DIET SUPPLEMENTATION;

AGED, 80 AND OVER; CHOLECALCIFEROL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; LONG-TERM CARE; MALE; ONTARIO; VITAMIN D; VITAMINS;

EID: 84862087266     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2012.03914.x     Document Type: Letter

References (9)

1. Lips P,. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: Consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477-501.
2. Bronner F,. Recent developments in intestinal calcium absorption. Nutr Rev 2009; 67: 109-113.
3. Holick MF, Chen TC,. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008; 87: 1080S-1086S.
4. Hanley DA, Cranney A, Jones G, et al., for the Guidelines Committee of the Scientific Advisory Council of Osteoporosis Canada Vitamin D in adult health and disease: A review and guideline statement from osteoporosis Canada. Can Med Assoc J 2010; 182: E610-E618.
5. National Osteoporosis Foundation. Clinician's Guide to Prevention and Treatment of Osteoporosis. Washington, DC: National Osteoporosis Foundation, 2010. Available at: Accessed September 8, 2011.
6. Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005; 16: 713-716.
7. Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: A meta-analysis of randomized controlled trials. Arch Intern Med 2009; 169: 551-561.
8. Mastaglia SR, Pellegrini GG, Mandalunis PM, et al. Vitamin D insufficiency reduces the protective effect of bisphosphonate on ovariectomy-induced bone loss in rats. Bone 2006; 39: 837-844.
9. Adami S, Giannini S, Bianchi G, et al. Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 2009; 20: 239-244.